SDHD Gene Carcinoid Tumors Intestinal Genetic Test sale cost 4400 AED
PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test sale cost 4400 AED PTCH2 Gene Basal Cell Nevus Syndrome Due to Germline PTCH2 Mutation Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test sale cost 4400 AED MSH6 Gene Colorectal Cancer Hereditary Nonpolyposis Type 5 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SDHD Gene Carcinoid Tumors Intestinal Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SDHD Gene Carcinoid Tumors Intestinal Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SDHD gene, which have been linked to the development of carcinoid tumors in the intestine. Carcinoid tumors are a type of slow-growing cancer that can occur in various parts of the body but are most commonly found in the gastrointestinal tract. These tumors can produce serotonin or other chemicals, leading to various symptoms known as carcinoid syndrome.

Mutations in the SDHD gene, part of a group of genes responsible for complex II in the mitochondrial electron transport chain, can predispose individuals to developing these tumors. Identifying mutations in this gene can help in assessing the risk of developing carcinoid tumors, guiding treatment options, and providing information for family planning.

The test is conducted at DNA Labs UAE, a facility known for its comprehensive genetic testing services. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the detailed insights it provides. Through a sample of blood or saliva, the test examines the DNA for specific mutations in the SDHD gene, offering a valuable tool for patients and healthcare providers in managing and understanding the risk of carcinoid tumors in the intestine.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SDHD Gene Carcinoid Tumors Intestinal Genetic Test

Are you concerned about the development of certain types of tumors, such as paragangliomas and pheochromocytomas? DNA Labs UAE offers the SDHD Gene Carcinoid Tumors Intestinal Genetic Test to provide valuable information for diagnosis, prognosis, and treatment decisions.

Test Details

The SDHD gene is associated with the development of certain types of tumors, including paragangliomas and pheochromocytomas. While these tumors are usually noncancerous (benign), they can become cancerous (malignant) in some cases. Carcinoid tumors, on the other hand, are a type of neuroendocrine tumor that can develop in various organs, including the intestines. These tumors can be either benign or malignant.

Our Next-Generation Sequencing (NGS) genetic testing method allows us to analyze multiple genes simultaneously to identify genetic mutations or alterations that may be associated with certain diseases or conditions, including cancer. In the case of the SDHD gene and carcinoid tumors, NGS genetic testing can detect any mutations or alterations in the SDHD gene that may contribute to the development of these tumors.

By identifying specific genetic mutations or alterations, our NGS testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can also help identify individuals who may be at an increased risk of developing these tumors, allowing for appropriate surveillance and preventive measures.

It’s important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling. Our team of oncologists and geneticists at DNA Labs UAE are dedicated to providing personalized recommendations and guidance based on each individual’s specific genetic profile and family history.

Test Name: SDHD Gene Carcinoid Tumors Intestinal Genetic Test

Components:

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cancer
  • Doctor: Oncologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the SDHD Gene Carcinoid Tumors Intestinal Genetic Test, it is essential to provide the clinical history of the patient who will be tested. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by SDHD Gene Carcinoid Tumors Intestinal NGS Genetic DNA Test gene SDHD.

Genetic counseling is crucial to ensure a comprehensive understanding of the test results and their implications. Our genetic counselors will guide you through the process, offering personalized recommendations and guidance based on your specific genetic profile and family history.

Don’t leave your health to chance. Get the SDHD Gene Carcinoid Tumors Intestinal Genetic Test at DNA Labs UAE today and gain valuable insights for your diagnosis, prognosis, and treatment decisions.

Test Name SDHD Gene Carcinoid tumors intestinal Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SDHD Gene Carcinoid tumors, intestinal NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SDHD Gene Carcinoid tumors, intestinal NGS Genetic DNA Test gene SDHD
Test Details

The SDHD gene is associated with the development of certain types of tumors, including paragangliomas and pheochromocytomas. These tumors are usually noncancerous (benign) but can become cancerous (malignant) in some cases.

Carcinoid tumors, on the other hand, are a type of neuroendocrine tumor that can develop in various organs, including the intestines. These tumors can be either benign or malignant.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic mutations or alterations that may be associated with certain diseases or conditions, including cancer. In the case of SDHD gene and carcinoid tumors, NGS genetic testing can be used to detect any mutations or alterations in the SDHD gene that may contribute to the development of these tumors.

By identifying specific genetic mutations or alterations, NGS testing can provide valuable information for diagnosis, prognosis, and treatment decisions. It can also help identify individuals who may be at an increased risk of developing these tumors, allowing for appropriate surveillance and preventive measures.

It’s important to note that genetic testing should be performed and interpreted by healthcare professionals with expertise in genetics and genetic counseling. They can provide personalized recommendations and guidance based on the individual’s specific genetic profile and family history.

SKU: TEST-4464 Category:

Related products